| Recruiting | Smart Measurement of Circulating Tumor DNA NCT06989814 | Erasmus Medical Center | N/A |
| Recruiting | Evaluation of Irinotecan Liposome (II) Combined With 5-FU, LV, and Bevacizumab for mCRC NCT06643793 | Affiliated Hospital of Nantong University | Phase 2 |
| Not Yet Recruiting | Robotic Right Hemicolectomy Versus Laparoscopic Right Hemicolectomy NCT06067620 | Jeremy Meyer | N/A |
| Recruiting | Effect of Gut Microbiota and Its Metabolites on the Efficacy of Immunotherapy in Metastatic Colorectal Cancer NCT06714903 | The First Hospital of Jilin University | — |
| Recruiting | Delayed Systemic Therapy Following Destructive Local Treatment of Pulmonary Oligometastases After No Evidence NCT06778382 | Shandong Cancer Hospital and Institute | Phase 2 |
| Recruiting | Simultaneous vs. Staged Resection of Colorectal Cancer With Synchronous Liver Metastases NCT06200831 | Oslo University Hospital | N/A |
| Recruiting | Localized Treatment Versus Palliative Chemotherapy in CRC Patients With 10 or More CRLM NCT06208371 | Sun Yat-sen University | Phase 3 |
| Recruiting | Factors Affecting the Results of Treatment of Patients With Colorectal Cancer NCT06050447 | Immanuel Kant Baltic Federal University | — |
| Recruiting | Postoperative Effects of Different Enterostomy Approaches NCT05853094 | Fudan University | N/A |
| Recruiting | Early Onset Colorectal Cancer Detection NCT06342401 | City of Hope Medical Center | — |
| Completed | Predicting Local and Distant Recurrence in T1 Colorectal Cancer NCT06314971 | City of Hope Medical Center | — |
| Unknown | Safety of Cetuximab and Trifluridin Tipiracil as the Third-line Therapy in the RASwt mCRC NCT05155124 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Phase 1 |
| Unknown | FMT Combined With Immune Checkpoint Inhibitor and TKI in the Treatment of CRC Patients With Advanced Stage NCT05279677 | Chinese Academy of Medical Sciences | Phase 2 |
| Unknown | Tislelizumab Plus Cetuximab and Irinotecan vs Third-line Standard-of-care in Refractory mCRC NCT05278351 | Shanghai Zhongshan Hospital | Phase 2 |
| Completed | Cardiopulmonary Exercise Test Data Averaging Methods and Preoperative Risk Assessment NCT05353127 | VieCuri Medical Centre | — |
| Terminated | TACE Plus Axitinib and Hydroxychlorquine for Liver-Dominant Metastatic Colorectal Cancer (CRC) NCT04873895 | Abramson Cancer Center at Penn Medicine | Phase 1 |
| Not Yet Recruiting | Chemoradiotherapy Sequenced Radical Surgery for Colorectal Cancer With PALNM NCT05129774 | Qilu Hospital of Shandong University | N/A |
| Unknown | LIVACOR Trial: Minimally Invasive LIVer And Simultaneous COlorectal Resection NCT05138094 | Fondazione Poliambulanza Istituto Ospedaliero | N/A |
| Completed | Sensitivity of Fecal Immunochemical Test (FIT) for Colorectal Cancer (CRC) Screening NCT05163236 | University Hospital, Brest | — |
| Completed | Changes in Coagulation in Colorectal Cancer Patients Undergoing Surgical Treatment NCT04744688 | University of Aarhus | — |
| Unknown | Effects of COVID-19 Pandemic on the Outcomes of Colorectal Cancer NCT04712292 | University of Bologna | — |
| Recruiting | Early Detection of Advanced Adenomas and Colorectal Cancer NCT06342440 | City of Hope Medical Center | — |
| Completed | CIRSE Emprint Microwave Ablation Registry NCT03775980 | Cardiovascular and Interventional Radiological Society of Europe | — |
| Completed | Combined Immunotherapy and Radiosurgery for Metastatic Colorectal Cancer NCT03507699 | Sheba Medical Center | Phase 1 |
| Unknown | Avelumab Combined With Cetuximab and Irinotecan for Treatment Refractory Metastatic Colorectal Microsatellite NCT03608046 | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Phase 2 |
| Unknown | The Effects of RFA in Combination With Second-line Chemotherapy and Bevacizumab on Unresectable CRLM NCT03686254 | Nanfang Hospital, Southern Medical University | Phase 2 / Phase 3 |
| Unknown | A Trial of CXD101 in Combination With Nivolumab in Patients With Metastatic Microsatellite-Stable Colorectal C NCT03993626 | Celleron Therapeutics Ltd. | Phase 1 / Phase 2 |
| Active Not Recruiting | Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases NCT02758951 | Koen Rovers | Phase 2 / Phase 3 |
| Completed | Significance of Benign Lymph Node Enlargement in Colorectal Cancer NCT06410729 | Peking University Third Hospital | — |
| Active Not Recruiting | The COLON Study: Colorectal Cancer Cohort NCT03191110 | Wageningen University | — |
| Completed | Tracheal Colonization and Outcome After Major Abdominal Cancer Surgery NCT04002128 | Osijek University Hospital | N/A |
| Unknown | Socioeconomic Position in Acute Colorectal Cancer Surgery NCT03581890 | Zealand University Hospital | — |